Uses, Side Effects, Price of Sugargic MV 1mg/500mg/0.2mg Tablet SR

Sugargic MV 1mg/500mg/0.2mg Tablet SR is an anti-diabetic medication used to treat type 2 diabetes in adults. It helps control blood sugar levels..

Take Sugargic MV 1mg/500mg/0.2mg Tablet SR with food at the same time every day. Your doctor will determine the appropriate dosage based on your condition and adjust it if needed.

Continue taking this medication, even if you feel well or your blood sugar is under control. Stopping without consulting your doctor could increase the risk of kidney damage, blindness, nerve problems, and limb loss. Remember to follow a healthy diet, exercise regularly, and lose weight as advised by your doctor to effectively manage diabetes.

The most common side effect of Sugargic MV 1mg/500mg/0.2mg Tablet SR is low blood sugar (hypoglycemia). Recognize the signs and carry a fast-acting glucose source, like sugary food or fruit juice, to manage it. Avoid alcohol, as it can increase the risk of low blood sugar. Other potential side effects include taste changes, nausea, diarrhea, stomach pain, headache, swelling, blurred vision, bone fracture, and respiratory tract infection. Some individuals may experience weight gain.

USES OF Sugargic MV 1mg/500mg/0.2mg Tablet SR

• Treatment of Type 2 diabetes mellitus

BENEFITS OF Sugargic MV 1mg/500mg/0.2mg Tablet SR

In Treatment of Type 2 diabetes mellitus

Sugargic MV 1mg/500mg/0.2mg Tablet SR is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. It also helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs.

Sugargic MV 1mg/500mg/0.2mg Tablet SR will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.

SIDE EFFECTS OF Sugargic MV 1mg/500mg/0.2mg Tablet SR

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

• Nausea
• Diarrhea
• Abdominal pain
• Hypoglycemia (low blood glucose level)

FAQs:

Q1. What is Sugargic MV 1mg/500mg/0.2mg Tablet SR? Sugargic MV 1mg/500mg/0.2mg Tablet SR is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves the blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers the blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor which lowers the postprandial (after meals) glucose levels in the body. This combination is not indicated for the treatment of Type 1 DM.

Q2. What are the possible side effects of Sugargic MV 1mg/500mg/0.2mg Tablet SR? The use of Sugargic MV 1mg/500mg/0.2mg Tablet SR is associated with common side effects like hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.

Q2. Are there any specific conditions in which Sugargic MV 1mg/500mg/0.2mg Tablet SR should not be taken? The use of Sugargic MV 1mg/500mg/0.2mg Tablet SR should be avoided in patients with known allergy to any of the components or excipients of this medicine. The use of this medicine is also avoided in patients with moderate to severe kidney disease and in patients with inflammatory bowel disease, colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis.